nach oben

Journal of Neurology

Erschienen in:

31.01.2017 | Review

Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults

verfasst von: Jane W. Chan

Erschienen in: Journal of Neurology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Since obesity has become an epidemic in industrialized nations, idiopathic intracranial hypertension (IIH) is now a more common neuro-ophthalmic disorder that causes visual loss and headaches. This review highlights the new diagnostic criteria for IIH and the new insights into the pathophysiologic mechanisms of IIH. Key diagnostic and monitoring techniques for papilledema include not only neuroimaging and the measurement of cerebrospinal fluid (CSF) pressure, but also perimetry, optical coherence tomography, and ocular sonography. The main findings of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) support acetazolamide as the mainstay for medical therapy. CSF diversion procedures, endovascular venous sinus stenting, and optic nerve sheath fenestration are all surgical options when IIH is refractory to medical treatment or when it presents fulminantly. Future clinical trials comparing these procedures will help develop better paradigms in the surgical management of IIH.

Friesner D, Rosenman R, Lobb BM, Tanne E (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 12(5):e372–e380CrossRefPubMed

Phillips PH, Repka MX, Lambert SR (1998) Pseudotumor cerebri in children. J AAPOS 2(1):33–38CrossRefPubMed

Lampl Y, Eshel Y, Kessler A, Fux A, Gilad R, Boaz M et al (2002) Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 72(5):642–643CrossRefPubMedPubMedCentral

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71(6):693–701CrossRefPubMedPubMedCentral

Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case–control study. Cephalalgia 35(7):553–562CrossRefPubMed

Yri HM, Ronnback C, Wegener M, Hamann S, Jensen RH (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21(12):1458–1464CrossRefPubMed

Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159–1165CrossRefPubMed

Wall M (2010) Idiopathic intracranial hypertension. Neurol Clin 28(3):593–617CrossRefPubMedPubMedCentral

Libien J, Kupersmith MJ, Blaner W, McDermott MP, Gao S, Liu Y et al (2017) Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci 372:78–84CrossRefPubMed

10.

Vieira DS, Masruha MR, Goncalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G et al (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28(6):609–613CrossRefPubMed

11.

De Simone R, Ranieri A, Bilo L, Fiorillo C, Bonavita V (2008) Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci 29(Suppl 1):S69–S78CrossRefPubMed

12.

De Simone R, Ranieri A (2015) The role of intracranial hypertension in the chronification of migraine. Neurol Sci 36(Suppl 1):23–28CrossRefPubMed

13.

Maralani PJ, Hassanlou M, Torres C, Chakraborty S, Kingstone M, Patel V et al (2012) Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 67(7):656–663CrossRefPubMed

14.

Kyung SE, Botelho JV, Horton JC (2014) Enlargement of the sella turcica in pseudotumor cerebri. J Neurosurg 120(2):538–542CrossRefPubMed

15.

Ranganathan S, Lee SH, Checkver A, Sklar E, Lam BL, Danton GH et al (2013) Magnetic resonance imaging finding of empty sella in obesity related idiopathic intracranial hypertension is associated with enlarged sella turcica. Neuroradiology 55(8):955–961CrossRefPubMedPubMedCentral

16.

Bidot S, Clough L, Saindane AM, Newman NJ, Biousse V, Bruce BB (2016) The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(2):120–125CrossRef

17.

Butros SR, Goncalves LF, Thompson D, Agarwal A, Lee HK (2012) Imaging features of idiopathic intracranial hypertension, including a new finding: widening of the foramen ovale. Acta Radiol 53(6):682–688CrossRefPubMed

18.

Saindane AM, Bruce BB (2014) Reply to “Enlarged CSF spaces in pseudotumor cerebri”. AJR Am J Roentgenol 203(4):W459CrossRefPubMed

19.

Bialer OY, Rueda MP, Bruce BB, Newman NJ, Biousse V, Saindane AM (2014) Meningoceles in idiopathic intracranial hypertension. AJR Am J Roentgenol 202(3):608–613CrossRefPubMedPubMedCentral

20.

Degnan AJ, Levy LM (2011) Narrowing of Meckel’s cave and cavernous sinus and enlargement of the optic nerve sheath in pseudotumor cerebri. J Comput Assist Tomogr 35(2):308–312CrossRefPubMed

21.

Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G et al (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60(9):1418–1424CrossRefPubMed

22.

Rohr A, Bindeballe J, Riedel C, van Baalen A, Bartsch T, Doerner L et al (2012) The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: a longitudinal, volumetric magnetic resonance imaging study. Neuroradiology 54(1):25–33CrossRefPubMed

23.

Horev A, Hallevy H, Plakht Y, Shorer Z, Wirguin I, Shelef I (2013) Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: a prospective MRI study. J Neuroimaging 23(3):375–378CrossRefPubMed

24.

Bono F, Giliberto C, Mastrandrea C, Cristiano D, Lavano A, Fera F et al (2005) Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 65(7):1090–1093CrossRefPubMed

25.

Kimberly HH, Shah S, Marill K, Noble V (2008) Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med 15(2):201–204CrossRefPubMed

26.

Bauerle J, Nedelmann M (2011) Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension. J Neurol 258(11):2014–2019CrossRefPubMed

27.

Singleton J, Dagan A, Edlow JA, Hoffmann B (2015) Real-time optic nerve sheath diameter reduction measured with bedside ultrasound after therapeutic lumbar puncture in a patient with idiopathic intracranial hypertension. Am J Emerg Med 33(6):860 e5–860 e7CrossRef

28.

Hassen GW, Nazeer O, Manizate F, Patel N, Kalantari H (2014) The role of bedside ultrasound in pretherapeutic and posttherapeutic lumbar puncture in patient with idiopathic intracranial hypertension. Am J Emerg Med 32(10):1298 e3–1298 e4CrossRef

29.

Hoffmann J, Huppertz HJ, Schmidt C, Kunte H, Harms L, Klingebiel R et al (2013) Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia 33(13):1075–1084CrossRefPubMed

30.

Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI et al (2003) Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM 96(7):481–490CrossRefPubMed

31.

Sinclair AJ, Walker EA, Burdon MA, van Beek AP, Kema IP, Hughes BA et al (2010) Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab 95(12):5348–5356CrossRefPubMed

32.

Boyle CD (2008) Recent advances in the discovery of 11beta-HSD1 inhibitors. Curr Opin Drug Discov Dev 11(4):495–511

33.

Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G et al (2016) Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. J Pain Res 9:223–232PubMedPubMedCentral

34.

Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87(9):982–992CrossRefPubMedPubMedCentral

35.

Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra11CrossRef

36.

Orefice G, Celentano L, Scaglione M, Davoli M, Striano S (1992) Radioisotopic cisternography in benign intracranial hypertension of young obese women. A seven-case study and pathogenetic suggestions. Acta Neurol (Napoli) 14(1):39–50

37.

Levitt MR, Albuquerque FC, Gross BA, Moon K, Jadhav AP, Ducruet AF et al (2016) Venous sinus stenting in patients without idiopathic intracranial hypertension. J Neurointerv Surg. doi:10.1136/neurintsurg-2016-012405

38.

Subramaniam S, Fletcher WA (2016) Obesity and weight loss in idiopathic intracranial hypertension: a narrative review. J Neuroophthalmol. doi:10.1097/WNO.0000000000000448

39.

Berdahl JP, Fleischman D, Zaydlarova J, Stinnett S, Allingham RR, Fautsch MP (2012) Body mass index has a linear relationship with cerebrospinal fluid pressure. Investig Ophthalmol Vis Sci 53(3):1422–1427CrossRef

40.

Kesler A, Kliper E, Shenkerman G, Stern N (2010) Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 117(1):169–174CrossRefPubMed

41.

Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA et al (2009) Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) 70(6):863–869CrossRef

42.

Klein A, Stern N, Osher E, Kliper E, Kesler A (2013) Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res 38(9):972–976CrossRefPubMed

43.

Kerty E, Heuser K, Indahl UG, Berg PR, Nakken S, Lien S et al (2013) Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol 91(1):88–91CrossRefPubMed

44.

Stiebel-Kalish H, Eyal S, Steiner I (2013) The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension. Med Hypotheses 81(6):1059–1062CrossRefPubMed

45.

Brettschneider J, Hartmann N, Lehmensiek V, Mogel H, Ludolph AC, Tumani H (2011) Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved? Cephalalgia 31(1):116–121CrossRefPubMed

46.

Edwards LJ, Sharrack B, Ismail A, Tench CR, Gran B, Dhungana S et al (2013) Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol 2(3):234–244PubMedPubMedCentral

47.

Keltner JL, Johnson CA, Cello KE, Wall M (2014) Group NIIHS. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Investig Ophthalmol Vis Sci 55(5):3200–3207CrossRef

48.

Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL et al (2016) Visual field outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Investig Ophthalmol Vis Sci 57(3):805–812CrossRef

49.

Corbett JJ, Jacobson DM, Mauer RC, Thompson HS (1988) Enlargement of the blind spot caused by papilledema. Am J Ophthalmol 105(3):261–265CrossRefPubMed

50.

Cello KE, Keltner JL, Johnson CA, Wall M, Group NIIHS (2016) Factors affecting visual field outcomes in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(1):6–12CrossRef

51.

Kardon R (2014) Optical coherence tomography in papilledema: what am I missing? J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 34(Suppl):S10–S17CrossRef

52.

Group OCTS-SCfNIIHS, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R et al (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Investig Ophthalmol Vis Sci 55(12):8173–8179

53.

Kupersmith MJ, Sibony P, Mandel G, Durbin M, Kardon RH (2011) Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema. Investig Ophthalmol Vis Sci 52(9):6558–6564CrossRef

54.

Sibony P, Kupersmith MJ, Honkanen R, Rohlf FJ, Torab-Parhiz A (2014) Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension. Investig Ophthalmol Vis Sci 55(12):8223–8231CrossRef

55.

Silverman AL, Tatham AJ, Medeiros FA, Weinreb RN (2014) Assessment of optic nerve head drusen using enhanced depth imaging and swept source optical coherence tomography. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 34(2):198–205CrossRef

56.

Optical Coherence Tomography Substudy Committee, NORDIC Idiopathic Intracranial Hypertension Study Group (2015) Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology 122(9):1939–1945CrossRef

57.

Chowdhury HR, Rajak S, Heath D, Brittain P (2015) Optical coherence tomography imaging of the optic nerve head pre optic and post optic nerve sheath fenestration. BMJ Case Rep. doi:10.1136/bcr-2014-204511

58.

Monteiro ML, Afonso CL (2014) Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye (London) 28(4):390–398CrossRef

59.

Afonso CL, Raza AS, Kreuz AC, Hokazono K, Cunha LP, Oyamada MK et al (2015) Relationship between pattern electroretinogram, frequency-domain OCT, and automated perimetry in chronic papilledema from pseudotumor cerebri syndrome. Invest Ophthalmol Vis Sci 56(6):3656–3665CrossRefPubMed

60.

Goldhagen BE, Bhatti MT, Srinivasan PP, Chiu SJ, Farsiu S, El-Dairi MA (2015) Retinal atrophy in eyes with resolved papilledema detected by optical coherence tomography. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 35(2):122–126

61.

Ohle R, McIsaac SM, Woo MY, Perry JJ (2015) Sonography of the optic nerve sheath diameter for detection of raised intracranial pressure compared to computed tomography: a systematic review and meta-analysis. J Ultrasound Med 34(7):1285–1294CrossRefPubMed

62.

Bagnato F, Good J (2016) The use of antiepileptics in migraine prophylaxis. Headache 56(3):603–615CrossRefPubMed

63.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL et al (2014) The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 34(2):107–117CrossRef

64.

Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50(4):1094–1098CrossRefPubMed

65.

Levy J, Yagev R, Petrova A, Lifshitz T (2006) Topiramate-induced bilateral angle-closure glaucoma. Can J Ophthalmol 41(2):221–225CrossRefPubMed

66.

Giuliari GP, Banda RM, Vann VR, Gonzalez VH, McMillin RB (2008) Closed-angle glaucoma after topiramate therapy for migraine in a patient with undiagnosed pseudotumor cerebri. Can J Ophthalmol 43(3):371CrossRefPubMed

67.

Alore PL, Jay WM, Macken MP (2006) Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective. Semin Ophthalmol 21(1):15–17CrossRefPubMed

68.

Celebisoy N, Gokcay F, Sirin H, Akyurekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116(5):322–327CrossRefPubMed

69.

Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46(5):1226–1230CrossRefPubMed

70.

Yri HM, Wegener M, Sander B, Jensen R (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259(5):886–894CrossRefPubMed

71.

Satti SR, Leishangthem L, Chaudry MI (2015) Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 36(10):1899–1904CrossRefPubMed

72.

Brodsky MC, Rettele GA (1998) Protracted postsurgical blindness with visual recovery following optic nerve sheath fenestration. Arch Ophthalmol 116(1):107–109PubMed

73.

Robinson ME, Moreau A, O’Meilia R, Pagteilan J, Ding K, Siatkowski RM et al (2016) The relationship between optic nerve sheath decompression failure and intracranial pressure in idiopathic intracranial hypertension. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(3):246–251CrossRef

74.

Woodworth GF, McGirt MJ, Elfert P, Sciubba DM, Rigamonti D (2005) Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension. Stereotact Funct Neurosurg 83(1):12–16CrossRefPubMed

75.

Kandasamy J, Hayhurst C, Clark S, Jenkinson MD, Byrne P, Karabatsou K et al (2011) Electromagnetic stereotactic ventriculoperitoneal csf shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg. 75(1):155–160 (discussion 32–3) CrossRefPubMed

76.

Alkosha HM, Zidan AS (2016) Role of lumbopleural shunt in management of idiopathic intracranial hypertension. World Neurosurg 88:113–118CrossRefPubMed

77.

Radvany MG, Solomon D, Nijjar S, Subramanian PS, Miller NR, Rigamonti D et al (2013) Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 33(2):117–122CrossRef

78.

Dinkin MJ, Patsalides A (2016) Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol. doi:10.1097/WNO.0000000000000426 PubMed

79.

Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ et al (2011) Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 32(8):1408–1414CrossRefPubMed

80.

Ahmed R, Friedman DI, Halmagyi GM (2011) Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 31(4):374–380CrossRef

81.

American College of Cardiology/American Heart Association Task Force on Practice Guidelines OEP (2013) Executive summary: Guidelines for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013. Obesity (Silver Spring) 22(Suppl 2):S5–S39

82.

Handley SC, Sun Y, Wyckoff MH, Lee HC (2015) Outcomes of extremely preterm infants after delivery room cardiopulmonary resuscitation in a population-based cohort. J Perinatol 35(5):379–383CrossRefPubMed

83.

Moss HE (2016) Bariatric Surgery and the Neuro-Ophthalmologist. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(1):78–84CrossRef

Titel: Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults
verfasst von: Jane W. Chan
Publikationsdatum: 31.01.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 8/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-017-8401-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

How does performance of the Friedreich Ataxia Functional Composite compare to rating scales?

Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis

The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension

Revisiting mitochondrial ocular myopathies: a study from the Italian Network

Posterior reversible encephalopathy syndrome